Blood Sugar Tracking Surge: Experts Say Most People Without Diabetes Don’t Need Continuous Monitoring
Interest in blood sugar tracking and consumer CGMs is growing, but endocrinologists say most people without diabetes do not need continuous glucose monitoring.
Blood sugar tracking has moved from clinical practice into mainstream fitness and wellness conversations, driven in part by social media and wearable-device marketing. Continuous glucose monitors (CGMs) that deliver real-time glucose readings are increasingly used by people without diabetes who want to optimize sleep, weight and energy. Endocrinologists caution that for most healthy individuals this level of monitoring is unnecessary and can generate anxiety rather than actionable health benefits.
Social media and the rise of consumer CGMs
Promotional posts and personal anecdotes on platforms like TikTok and Instagram have popularized CGMs as tools for self-optimization beyond diabetes care. Influencers often showcase food experiments and “spike”-based challenges, encouraging followers to measure how meals or habits affect glucose. The result is a rapid spread of blood sugar tracking among people seeking immediate biometric feedback rather than clinically guided assessment.
Device manufacturers and third-party services have also expanded access, presenting CGMs as lifestyle technology rather than medical equipment. That shift has blurred lines between clinically indicated monitoring and consumer curiosity, prompting clinicians to speak publicly about appropriate use. Experts say broader availability can be helpful for some, but it risks normalizing intrusive measurement for people who derive little medical benefit.
How glucose regulation and CGMs work
Glucose is the principal sugar circulating in the bloodstream and the body’s main energy source; levels naturally rise after eating and fall between meals. A functioning pancreas releases insulin to lower elevated glucose, keeping concentrations within a narrow range for most healthy people. CGMs measure interstitial glucose through a subcutaneous sensor and report trends, not instantaneous blood values, which is important when interpreting short-term fluctuations.
Because CGM sensors sample interstitial fluid rather than capillary blood, readings can lag slightly behind true blood glucose and vary in accuracy, especially at low or rapidly changing levels. Devices were developed and validated for people with diabetes who require precise glucose control, so translating those same metrics to healthy populations demands caution. Clinicians warn against equating every post-meal rise with pathology.
Experts: monitoring can cause unnecessary worry
Sun Kim, MD, an associate professor of endocrinology at Stanford University, cautions that small, temporary rises in glucose are normal and expected after meals. She and other diabetes specialists say obsessing over minor excursions can lead healthy people to believe their bodies are malfunctioning when they are not. That reaction can prompt unnecessary dietary restrictions, expense and psychological stress without clear evidence of long-term benefit.
Raimund Herzog, MD, an endocrinologist at Yale Medicine, points out that sensor accuracy is still imperfect for people without glucose disorders, and misinterpreting readings could encourage counterproductive changes. Both clinicians emphasize that monitoring tools should complement, not replace, clinical judgment and evidence-based lifestyle advice.
Who may benefit from targeted monitoring
Clinicians agree there are groups for whom glucose tracking can be informative, including people with diagnosed prediabetes, gestational diabetes, or metabolic conditions identified by a healthcare provider. For these patients, intermittent or continuous monitoring can reveal patterns that lifestyle interventions or medication can address. When used in partnership with clinicians, CGMs may help motivate behavior change and guide tailored treatment plans.
Outside those specific indications, routine use of CGMs by otherwise healthy adults has not been shown to prevent diabetes or improve long-term outcomes. Experts generally recommend that people concerned about blood sugar consult a clinician for testing and risk assessment rather than self-prescribing continuous monitoring based on social media trends.
Behavioral measures that control blood glucose
Endocrinologists emphasize traditional, evidence-based strategies to maintain healthy glucose regulation: a balanced diet rich in fiber and whole foods, regular physical activity, adequate sleep, and hydration. These measures reduce the frequency and magnitude of post-meal spikes more reliably than short-term tweaks guided solely by CGM feedback. Maintaining a healthy weight and routine meal timing can also stabilize glucose without requiring continuous sensors.
Practical habits include prioritizing vegetables and lean proteins, choosing whole fruit over juices or processed sweets, and replacing sugary beverages with water. Regular moderate exercise improves insulin sensitivity, and consistent sleep supports metabolic health, addressing several of the non-food triggers that can elevate glucose.
Cost, accessibility and public health implications
CGMs remain relatively expensive and are typically designed for medical use, which raises questions about cost-effectiveness for wellness applications. When people without clinical indications adopt continuous monitoring, they may divert resources from medically indicated care or create demand that complicates insurance coverage policies. Public health experts warn against normalizing expensive interventions without solid evidence of population-level benefit.
Wider adoption driven by consumer trends could also shift expectations about medical monitoring and personal responsibility for health metrics. Policymakers and clinicians face a challenge in balancing innovation and access with clear guidance to prevent overuse and commercial exploitation of medical technology.
For most people without diabetes, occasional natural fluctuations in glucose are normal and not a sign of disease; targeted clinical testing and established lifestyle measures remain the most reliable way to manage metabolic risk. Continuous glucose monitors have proven value for people who need tight glucose control, but specialists advise that blood sugar tracking for general wellness should be approached cautiously and under medical guidance when used at all.
